8086 On Other Exchanges
Symbol
Exchange
8086 is not on other exchanges.

nipro corp (8086) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for NIPRO CORP (8086)

Related News

No related news articles were found.

nipro corp (8086) Related Businessweek News

View More BusinessWeek News

nipro corp (8086) Details

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and glass businesses worldwide. The company’s Medical Device business offers a range of disposable medical products comprising renal products, intervention and anesthesiology products, injection and infusion products, cardiopulmonary products, and diabetic products. Its Pharmaceutical business provides pharmaceutical combination products, including double bags, pre-filled syringes, and half-type kits; transdermal therapeutic systems, orally disintegrating tablets and films, kit preparations, and drug delivery systems; and pharmaceutical contract manufacturing services. The company’s Pharma Packaging business offers glass molding vials, ampoules, syringes, and cartridges; glass tubes for pharmaceuticals; glass forming machinery; and other parts of pharmaceutical packaging rubber plugs, as well as glass bulbs for vacuum flasks. Its Other business provides thermostable enzymes for clinical chemistry. The company was founded in 1954 and is based in Osaka, Japan.

24,243 Employees
Last Reported Date: 06/28/16
Founded in 1954

nipro corp (8086) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

nipro corp
Mitsubishi Tanabe Pharma To Sell Drug Sales Unit To Nipro

Mitsubishi Tanabe Pharma Corporation (TSE:4508) says the co will transfer generic drug business and part of long-listed drugs business to Nipro Corporation (TSE:8086) via company division . Says the co plans to sell 100 percent stake in the drug sales unit to Nipro Corp.

Nipro Plans to Open USD 300 Million Medical Plant in Vietnam

Nipro plans to open its second facility in Vietnam, as part of Vietnam's growing pharmaceutical industry. The USD300 million plant will be responsible for manufacturing dialysis treatment equipment such as catheters and blood tubing, which will be sold predominantly in Japan and Southeast Asia. After an initial capital investment of USD190 million - which will be allocated to building the site - a further USD110 millionwill be invested to boost capacity. The new factory is to be built in Ho Chi Minh City's Saigon Hi-tech Park and will begin construction this month. The plant's first products are predicted to hit the market in October 2018.

Nipro Corporation Reports Consolidated Earnings Results for the Nine Months Ended December 31, 2016; Provides Consolidated Earnings Guidance for the Year Ending March 31, 2017

Nipro Corporation reported consolidated earnings results for the nine months ended December 31, 2016. For the period, the company has reported net sales of ¥270,187 million, operating income of ¥26,148 million, ordinary income of ¥23,700 million and net income attributable to owners of parent of ¥14,071 million or ¥83.52 per basic share compared to net sales of ¥274,061 million, operating income of ¥18,431 million, ordinary income of ¥13,884 million and net income attributable to owners of parent of ¥13,968 million or ¥82.35 per basic share a year ago. Income before income taxes was ¥22,560 million against ¥12,038 million reported last year. The company provided consolidated earnings guidance for the year ending March 31, 2017. For the year, the company expects net sales of ¥363,000 million, operating income of ¥29,000 million, ordinary income of ¥20,000 million and net income of ¥12,500 million or ¥74.44 per share.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

8086 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 8086.
View Industry Companies
 

Industry Analysis

8086

Industry Average

Valuation 8086 Industry Range
Price/Earnings 15.6x
Price/Sales 0.8x
Price/Book 1.8x
Price/Cash Flow 14.6x
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact NIPRO CORP, please visit www.nipro.co.jp. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.